Early warning system for heart failure or heart attack patients
Part of Heart & circulation clinical trials.
This study tests a sensor that monitors oxygen levels in body tissues to help doctors spot when your heart is not pumping enough blood early. The goal is to catch problems sooner so you can get faster treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You weigh more than 40 kg (about 88 pounds)
- You are in the hospital because of severe heart failure symptoms or you had a heart attack and are getting a heart catheter test
- You are in the intensive care unit (ICU)
- You are not allergic to medical tape or adhesive
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, non-invasive vest-like device (ReDS) that measures fluid in the lungs of people who had a heart attack and then developed heart failure symptoms after their procedure. It helps doctors monitor fluid levels to improve recovery and outcomes.
This study tests a special monitoring approach (likely using an implanted device) to help prevent serious complications after you survive cardiogenic shock in the hospital. It may help the care team detect problems earlier so treatments can start sooner.
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
This study tests a small chest sensor that tracks your heart activity while you're in the hospital. It may help doctors better manage heart failure and prevent future crises.
This trial tests a new wearable sensor (like a smart bandage) that tracks your heart rate, breathing, and other vital signs continuously, compared to standard monitoring. It aims to see if this sensor is just as good at keeping an eye on you in busy hospital settings, potentially allowing more freedom of movement.
This study tests a special sensor (near-infrared spectroscopy) that checks blood flow to the heart and other organs during heart surgery. It may help doctors monitor and improve care for children having complex heart procedures.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.